PTEN loss stimulates prostate tumor progression by sustaining AKT activation. Nowak et al. (2019. J. Cell Biol. https://doi.org/10.1083/jcb.201902048) surprisingly show that the AKT-suppressing phosphatase PHLPP2 promotes disease progression in the context of dual PTEN and p53 loss by increasing MYC stability.
You may also like
Passive muscle tension increases in proportion to intramuscular fluid volume [SHORT COMMUNICATION]
- November 16, 2019
David A. Sleboda, Ethan S. Wold,Read more
Type I interferon limits mast cell–mediated anaphylaxis by controlling secretory granule homeostasis
- November 15, 2019
by Toshihiko Kobayashi, Shiho Shimabukuro-Demoto,Read more